These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 13765381)
1. Vasodilators and the use of cyclospasmol in peripheral vascular disease. MAHL MM Angiology; 1961 Sep; 12():432-4. PubMed ID: 13765381 [No Abstract] [Full Text] [Related]
3. Effects of cyclandelate (cyclospasmol) in treatment of circulatory disturbances. LESLIE RE Tex State J Med; 1960 May; 56():352-6. PubMed ID: 14415999 [No Abstract] [Full Text] [Related]
4. A clinical study of a musculotropic vasodilating compound. SHAFTEL HE; SAMUELS S; PADERNACHT E Angiology; 1961 Sep; 12():423-6. PubMed ID: 13750570 [No Abstract] [Full Text] [Related]
5. A new vasodilating and antispasmodic agent: isoxsuprine hydrochloride. KAINDL F; SAMUELS SS; SELMAN D; SHAFTEL H Angiology; 1959 Aug; 10():185-92. PubMed ID: 14404026 [No Abstract] [Full Text] [Related]
6. [Use of a product of esterification of mandelic acid with 3,5,5-triethylcyclohexanol (cyclospasmol) in the treatment of peripheral arteriopathy]. STARACE G; NOFERI A; PADULA R Gazz Med Ital; 1960 Apr; 119():133-6. PubMed ID: 13833815 [No Abstract] [Full Text] [Related]
7. Clinical results with high doses of cyclandelate. HORNSTEIN LS Angiology; 1961 Sep; 12():435-9. PubMed ID: 13715920 [No Abstract] [Full Text] [Related]
8. The treatment of peripheral vascular diseases with cyclospasmol (mandelic acid ester of 3, 5, 5-trimethylcyclohexanol). VAN WIJK TW Angiology; 1953 Apr; 4(2):103-13. PubMed ID: 13040814 [No Abstract] [Full Text] [Related]
9. [Treatment of disorders of the peripheral circulation by the amygdalic ester of 3,5,5-trimethylcyclohexanol]. RAVINA A Presse Med (1893); 1960 Jun; 68():1240-2. PubMed ID: 14436571 [No Abstract] [Full Text] [Related]
10. Clinical experiences with isoxsuprine. CLARKSON IS; LE PERE DM Angiology; 1960 Jun; 11():190-2. PubMed ID: 13810525 [No Abstract] [Full Text] [Related]
11. [Duvadilan: a new peripheral vasodilator]. MARTORELL A Angiologia; 1959; 11():241-4. PubMed ID: 14421881 [No Abstract] [Full Text] [Related]
13. [On the use in medical therapy of peripheral arteriopathies of an enzymatic complex in association with a peripheral vasodilator]. STARACE G; NOFERI A Minerva Cardioangiol; 1959 Oct; 7():545-50. PubMed ID: 13833816 [No Abstract] [Full Text] [Related]
14. A quantitative appraisal of the value of vasodilators in occlusive peripheral arterial disease. GILLESPIE JA Bull Soc Int Chir; 1962; 21():69-72. PubMed ID: 13898634 [No Abstract] [Full Text] [Related]
15. [Therapeutic trial of a vasodilator in arteriopathy of the extremities. Evaluation of results and discussion on the use of vasodilators in arteritis]. PIERRON J Mars Med; 1960; 97():641-5. PubMed ID: 14432867 [No Abstract] [Full Text] [Related]
16. The pharmacology of cyclospasmol. BIJLSMA UG; FUNCKE AB; TERSTEEGE HM; REKKER RF; ERNSTING MJ; NAUTA WT Arch Int Pharmacodyn Ther; 1956 Feb; 105(1-2):145-74. PubMed ID: 13314726 [No Abstract] [Full Text] [Related]
17. Clinical experience with tensodin, a vasodilator. SAMUELS SS N Y State J Med; 1956 Jun; 56(11):1804-7. PubMed ID: 13322275 [No Abstract] [Full Text] [Related]
18. Effect of a vasodilator isoxsuprine, on cerebral ischemic episodes. DHRYMIOTIS AD; WHITTIER JR Curr Ther Res Clin Exp; 1962 Apr; 4():124-9. PubMed ID: 13885968 [No Abstract] [Full Text] [Related]